A phase III trial of nab-paclitaxel (nab-P) vs dacarbazine (DTIC) in chemotherapy-naive patients with metastatic melanoma: analysis by age

R. Kefford; E. Hersh; M. Del Vecchio; M. P. Brown; C. Loquai; A. Testori; C. Robert; M. Li; null Elias; M. F. Renschler; A. Hauschild

A phase III trial of nab-paclitaxel (nab-P) vs dacarbazine (DTIC) in chemotherapy-naive patients with metastatic melanoma: analysis by age

R. Kefford, E. Hersh, M. Del Vecchio, M. P. Brown, C. Loquai, A. Testori, C. Robert, M. Li, Elias, M. F. Renschler, A. Hauschild

Research output: Contribution to journal › Meeting abstract

Original language	English
Article number	P-100
Pages (from-to)	55-56
Number of pages	2
Journal	JDDG - Journal of the German Society of Dermatology
Volume	11
Issue number	Supplement 7
Publication status	Published - Jul 2013
Externally published	Yes
Event	9 Congress of the European Association of Dermatology (EADO), 7 Interdisciplinary Melanoma/Skin Cancer Meeting, 3 European Post-Chicago Melanoma Meeting - Hamburg, Germany, Hamburg, Germany Duration: 17 Jul 2013 → 20 Jul 2013

Cite this

Kefford, R., Hersh, E., Del Vecchio, M., Brown, M. P., Loquai, C., Testori, A., Robert, C., Li, M., Elias, Renschler, M. F., & Hauschild, A. (2013). A phase III trial of nab-paclitaxel (nab-P) vs dacarbazine (DTIC) in chemotherapy-naive patients with metastatic melanoma: analysis by age. JDDG - Journal of the German Society of Dermatology, 11(Supplement 7), 55-56. Article P-100.

@article{85df0ac52ade41568d3d539180afe0d8,

title = "A phase III trial of nab-paclitaxel (nab-P) vs dacarbazine (DTIC) in chemotherapy-naive patients with metastatic melanoma: analysis by age",

author = "R. Kefford and E. Hersh and {Del Vecchio}, M. and Brown, {M. P.} and C. Loquai and A. Testori and C. Robert and M. Li and Elias and Renschler, {M. F.} and A. Hauschild",

year = "2013",

month = jul,

language = "English",

volume = "11",

pages = "55--56",

journal = "JDDG - Journal of the German Society of Dermatology",

issn = "1610-0379",

publisher = "Wiley-Blackwell, Wiley",

number = "Supplement 7",

note = "9 Congress of the European Association of Dermatology (EADO), 7 Interdisciplinary Melanoma/Skin Cancer Meeting, 3 European Post-Chicago Melanoma Meeting ; Conference date: 17-07-2013 Through 20-07-2013",

}

Kefford, R, Hersh, E, Del Vecchio, M, Brown, MP, Loquai, C, Testori, A, Robert, C, Li, M, Elias, Renschler, MF & Hauschild, A 2013, 'A phase III trial of nab-paclitaxel (nab-P) vs dacarbazine (DTIC) in chemotherapy-naive patients with metastatic melanoma: analysis by age', JDDG - Journal of the German Society of Dermatology, vol. 11, no. Supplement 7, P-100, pp. 55-56.

TY - JOUR

T1 - A phase III trial of nab-paclitaxel (nab-P) vs dacarbazine (DTIC) in chemotherapy-naive patients with metastatic melanoma

T2 - 9 Congress of the European Association of Dermatology (EADO), 7 Interdisciplinary Melanoma/Skin Cancer Meeting, 3 European Post-Chicago Melanoma Meeting

AU - Kefford, R.

AU - Hersh, E.

AU - Del Vecchio, M.

AU - Brown, M. P.

AU - Loquai, C.

AU - Testori, A.

AU - Robert, C.

AU - Li, M.

AU - Elias, null

AU - Renschler, M. F.

AU - Hauschild, A.

PY - 2013/7

Y1 - 2013/7

UR - https://doi.org/10.1111/ddg.12162

M3 - Meeting abstract

SN - 1610-0379

VL - 11

SP - 55

EP - 56

JO - JDDG - Journal of the German Society of Dermatology

JF - JDDG - Journal of the German Society of Dermatology

IS - Supplement 7

M1 - P-100

Y2 - 17 July 2013 through 20 July 2013

ER -

A phase III trial of nab-paclitaxel (nab-P) vs dacarbazine (DTIC) in chemotherapy-naive patients with metastatic melanoma: analysis by age

Other files and links

Cite this